Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$3.64 -0.12 (-3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ironwood Pharmaceuticals (IRWD) Non Operating Interest Expenses (2010 - 2026)

Updated

Ironwood Pharmaceuticals (IRWD) posted Non Operating Interest Expenses of $7.2 million for Q2 2026, down 13.8% from $8.36 million a year earlier and down 21.2% from the prior quarter.

Analysis

Ironwood Pharmaceuticals (IRWD) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Ironwood Pharmaceuticals was $32.66 million, down 6.0% year-over-year; for FY2025, it came in at $32.75 million, down 0.9% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
  • In prior years, Ironwood Pharmaceuticals' Non Operating Interest Expenses was $33.03 million in FY2024 (+52.7%), $21.63 million in FY2023 (+184.7%), $7.6 million in FY2022 (-75.6%) and $31.15 million in FY2021 (+5.7%).
  • The Q2 2026 figure stands as the lowest quarterly Non Operating Interest Expenses since Q2 2023.
  • On a year-over-year basis, Non Operating Interest Expenses increased in four of the last eight quarters, with growth averaging 0.3%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2023, with growth of 545.6%; the weakest was Q4 2022, with a decline of 80.8%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $9.14 million (Q1 2026), $7.89 million (Q4 2025) and $8.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Ironwood Pharmaceuticals 621.30 Mn -34.16 Mn - 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.20 Mn
Mar 31, 2026 9.14 Mn
Dec 31, 2025 7.89 Mn
Sep 30, 2025 8.43 Mn
Jun 30, 2025 8.36 Mn
Mar 31, 2025 8.07 Mn
Dec 31, 2024 8.91 Mn
Sep 30, 2024 9.42 Mn
Jun 30, 2024 7.47 Mn
Mar 31, 2024 7.23 Mn
Dec 31, 2023 8.42 Mn
Sep 30, 2023 9.84 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.53 Mn
Sep 30, 2022 1.52 Mn
Jun 30, 2022 2.21 Mn
Mar 31, 2022 2.34 Mn
Dec 31, 2021 7.95 Mn
Sep 30, 2021 7.84 Mn
API Access

Ironwood Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IRWD&period=max&api_key=YOUR_API_KEY